ÇコÄÉ¾î ºÐ¾ß »ý¼ºÇü AI ¼¼°è ½ÃÀåÀº 2023³â 18¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³âºÎÅÍ 2032³â±îÁö 33.2%ÀÇ °ß°íÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ·¯ÇÑ ±Þ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº µö·¯´×°ú ÀÚ¿¬¾î ó¸®(NLP)ÀÇ ¹ßÀü, ¸ÂÃãÇü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, AI ±â¹Ý ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Àü ¼¼°è ÇコÄÉ¾î µ¥ÀÌÅÍÀÇ ±ÞÁõ µîÀÌ ÀÖ½À´Ï´Ù.
»ý¼ºÇü AI´Â ÀÇ·á ¿µ»ó ºÐ¼®, ÀÚµ¿ º¸°í, ȯÀÚ Âü¿©¸¦ À§ÇÑ ´ëÈÇü µµ±¸ µî Çõ½ÅÀûÀÎ ¾ÖÇø®ÄÉÀ̼ÇÀ» °¡´ÉÇϰÔÇÔÀ¸·Î½á ÇコÄÉ¾î »ê¾÷À» º¯È½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ÀÇ·á ¼ºñ½º Á¦°øÀÚ¿Í Á¶Á÷ÀÌ AI ¼Ö·ç¼ÇÀ» ¾÷¹«¿¡ ÅëÇÕÇϵµ·Ï Àå·ÁÇÏ°í ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 18¾ï ´Þ·¯ |
¿¹»ó ±Ý¾× | 202¾ï ´Þ·¯ |
CAGR | 33.2% |
¿ëµµº°·Î´Â ÀÇ·á ¿µ»ó ºÐ¼® ¹× Áø´Ü, ½Å¾à °³¹ß, ȯÀÚ Áö¿ø, ¸ÂÃãÇü Ä¡·á µîÀÇ ºÎ¹®À¸·Î ³ª´¹´Ï´Ù. ÀÇ·á ¿µ»ó ºÐ¼® ¹× Áø´Ü ºÐ¾ß´Â Áúº´À» Á¶±â¿¡ Á¤È®ÇÏ°Ô °¨ÁöÇÒ ¼ö Àִ ÷´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ 2023³â °¡Àå ³ôÀº ¼öÀÍÀ» âÃâÇÏ¸ç ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù.
»ý¼ºÇü AI´Â ÀáÀçÀûÀÎ °Ç° À§ÇèÀ» Á¶±â¿¡ ÆÄ¾ÇÇÏ¿© Áø´Ü ´É·ÂÀ» Çâ»ó½Ã۰í, ÀÇ·á ¼ºñ½º Á¦°øÀÚ°¡ °á°ú¸¦ °³¼±ÇÏ°í ¿¹¹æ ÀÇ·á¿¡ ÁýÁßÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇϸç, AI ±â¹Ý µµ±¸´Â Á¤È®ÇÏ°í ºü¸¥ ºÐ¼®À» Á¦°øÇÏ¿© ÀÇ·á ¿µ»ó ¹× Áø´Ü¿¡ ´ëÇÑ Ã¤ÅÃÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚ, ÇコÄɾî Á¦°øÀÚ, Á¦¾àȸ»ç, ÀÇ·á ÁöºÒÀÚ µîÀ¸·Î ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. ÀÌ Áß ÀÇ·á ¼ºñ½º Á¦°øÀÚ´Â 2023³â¿¡ Áö¹èÀûÀÎ ºÎ¹®À¸·Î ºÎ»óÇÏ¿© ¿¹Ãø ±â°£ÀÌ ³¡³¯ ¶§±îÁö 97¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®¿¡¼ º´¿ø, Áø·á¼Ò, Áø´Ü ¼¾ÅÍ´Â ¿öÅ©ÇÃ·Î¿ì °£¼ÒÈ, ȯÀÚ Ä¡·á ÃÖÀûÈ, ½ºÄÉÁÙ¸µ ¹× ±â·Ï °ü¸®¿Í °°Àº °ü¸® ¾÷¹«¿¡ AI¸¦ Ȱ¿ëÇÏ´Â »ç·Ê°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
»ý¼ºÇü AI´Â ¹Ýº¹ÀûÀÎ ÀÛ¾÷À» ÀÚµ¿ÈÇϰí, ¿öÅ©Ç÷οì È¿À²¼ºÀ» ³ôÀ̰í, ÀÎÀû ¿À·ù¸¦ ÃÖ¼ÒÈÇÔÀ¸·Î½á ÀÇ·á ¼ºñ½º Á¦°øÀÚÀÇ ¿î¿µ ºñ¿ëÀ» Àý°¨ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ÀÚ¿ø ¹èºÐÀ» °³¼±Çϰí ÀçÀÔ¿øÀ²À» ³·Ãç ±Ã±ØÀûÀ¸·Î ºñ¿ë È¿À²ÀûÀÎ ÀÇ·á ¼ºñ½º Á¦°ø¿¡ ±â¿©ÇÕ´Ï´Ù.
ºÏ¹Ì´Â 2023³â 7¾ï 5,870¸¸ ´Þ·¯·Î °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, 2032³â±îÁö Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ Ã·´Ü ÀÇ·á ÀÎÇÁ¶ó´Â ÀüÀÚ ÀÇ·á ±â·Ï(EHR), ¿ø°ÝÀÇ·á ¹× ±âŸ µðÁöÅÐ µµ±¸ÀÇ ±Þ¼ÓÇÑ µµÀÔ°ú ÇÔ²² »ý¼ºÇü AI µµÀÔÀ» À§ÇÑ ºñ¿ÁÇÑ Åä¾çÀ» Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
The Global Generative AI In Healthcare Market, valued at USD 1.8 billion in 2023, is projected to grow at a robust CAGR of 33.2% from 2024 to 2032. This rapid growth is primarily fueled by advancements in deep learning and natural language processing (NLP), the increasing need for personalized treatments, rising investments in AI-driven healthcare solutions, and the surging volume of healthcare data worldwide.
Generative AI is transforming the healthcare industry by enabling innovative applications such as medical imaging analysis, automated reporting, and conversational tools for patient engagement. These technological advancements are encouraging healthcare providers and organizations to integrate AI solutions into their operations, driving market expansion.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $1.8 Billion |
Forecast Value | $20.2 Billion |
CAGR | 33.2% |
In terms of application, the market is divided into segments such as medical image analysis and diagnostics, drug discovery, patient assistance, personalized treatment, and more. The medical image analysis and diagnostics segment led the market in 2023, generating the highest revenue, owing to the increasing demand for advanced tools that enable early and accurate disease detection.
Generative AI enhances diagnostic capabilities by identifying potential health risks at an earlier stage, helping healthcare providers improve outcomes and focus on preventive care. AI-powered tools offer precise and rapid analysis, significantly boosting their adoption in medical imaging and diagnostics.
The market is further segmented by end use, encompassing healthcare providers, pharmaceutical companies, and healthcare payors. Among these, healthcare providers emerged as the dominant segment in 2023 and are expected to reach USD 9.7 billion by the end of the forecast period. Within this segment, hospitals, clinics, and diagnostic centers are increasingly leveraging AI to streamline workflows, optimize patient care, and manage administrative tasks like scheduling and record keeping.
Generative AI plays a crucial role in reducing operational costs for healthcare providers by automating repetitive tasks, enhancing workflow efficiency, and minimizing human errors. These solutions also contribute to better resource allocation and lower hospital readmission rates, ultimately supporting cost-effective healthcare delivery.
North America accounted for the largest revenue share of USD 758.7 million in 2023 and is anticipated to grow significantly through 2032. The region's advanced healthcare infrastructure, coupled with its rapid adoption of electronic health records (EHR), telemedicine, and other digital tools, creates a fertile ground for generative AI adoption. These factors are expected to drive market growth in the coming years.